The genotoxic and cytotoxic effects of ribavirin in rat bone marrow

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 521, Issue 1-2, 2002, Pages 179-185

  Narayana, K ^a   D'Souza, Urban J A ^a   Seetharama Rao, K P ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

Author keywords

Antiviral drugs; Genotoxicity; Micronucleus test; Mutagenicity

Indexed keywords

ANTIVIRUS AGENT; CYCLOPHOSPHAMIDE; RIBAVIRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TOXICITY; CELL DESTRUCTION; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG METABOLISM; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; GENOTOXICITY; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SAMPLING; SEX DIFFERENCE;

ANIMALS; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICRONUCLEUS TESTS; MUTAGENS; RATS; RATS, WISTAR; RIBAVIRIN; SEX FACTORS;

EID: 0037180366     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00239-5     Document Type: Article

References (37)

1. Sidwell R.W., Huffman J.H., Khare G.P., Allen L.B., Witkowski J.T., Robins R.K. Broad spectrum antiviral activity of virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 177:1972;705-706.
2. Allen L.B., Huffman J.H., Sidwell R.W. Failure of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole, ICN-1229) to stimulate interferon. Antimicrob. Agents. Chemother. 3:1973;534-535.
3. S. Budavari, Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals, 12th Ed., Merck & Co. Inc., White house station, NJ, 1996, pp. 8365.
4. Di Bisceglie A.M., Thompson J., Smith-Wilkaitis N., Brunt E.M., Bacon B.R. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Hepatology. 33(3):2001;704-707.
5. Wray S.K., Gilbert B.E., Noall M.W., Knight V. Mode of action of ribavirin: effect of nucleoside pool alterations on influenza virus ribonucleo-protein synthesis. Antiviral. Res. 5(1):1985;29-37.
6. Goswami B.B., Borek E., Sharma O.K., Fujitaki J., Smith R.A. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem. Biophys. Res. Commun. 89(3):1979;830-836.
7. Sidwell R.W., Bailey K.W., Wong M.H., Huffman J.H. In vitro and in vivo sensitivity of a non mouse adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Chemotherapy. 41(6):1995;455-461.
8. Jordan I., Briese T., Averett D.R., Lipkin W.I. Inhibition of Borna disease virus replication by ribavirin. J. Virol. 73(9):1999;7903-7906.
9. K. Parfitt, Martindale: The Complete Drug Reference, 32nd ed., Pharmaceutical Press, MA, 1999, 626 pp.
10. C.A. Laughlin, C.K. Tseng, Antiviral agents, RNA viruses other than HIV, in: M.E. Wolff (Ed.), Burger's Medicinal Chemistry and Drug Discovery, Wiley, New York, 1997, pp. 565-576.
11. Cozzolongo R., Cuppone R., Giannuzzi V., Amati L., Caradonna L., Tamborrino V., Jirillo E., Manghisi O.G. Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon. Aliment. Pharmacol. Ther. 15(11):2001;129-135.
12. Prince G.A. An update on respiratory syncytial virus antiviral agents. Expert Opin. Investig. Drugs. 10(2):2001;297-308.
13. Canonico P.G., Kastello M.D., Spears C.T., Brown J.R., Kackson E.A., Jenkins D.E. Effects of ribavirin on red blood cells. Toxicol. Appl. Pharmacol. 74(2):1984;155-162.
14. Canonico P.G., Kastello M.D., Cosgriff T.M., Donovan J.C., Ross P.E., Spears C.T., Stephen E.L. Hematological and bone marrow effects of ribavirin in rhesus monkeys. Toxicol. Appl. Pharmacol. 74(2):1984;163-172.
15. Cosgriff T.M., Hodgson L.A., Canonico P.G., White J.D., Kastello M.D., Donovan J.C., Ross P.E. Morphological alterations in blood and bone marrow of ribavirin-treated monkeys. Acta Haematol. 72(3):1984;195-200.
16. Steele R.W., Crosby D.L., Steele T.W., Pilkington N.S. Jr., Charlton R.K. Effects of ribavirin on neutrophil function. Am. J. Med. Sci. 295(6):1988;503-506.
17. Weiss R.C., Cox N.R., Boudreaux M.K. Toxicologic effects of ribavirin in cats. J. Vet. Pharmacol. Ther. 16(3):1993;301-316.
18. American Medical Association (AMA), Drug Evaluations: Antiviral Agents, 1993, pp. 1736-1748.
19. Kilham L., Ferm V.H. Congenital anomalies induced in hamster embryos with ribavirin. Science. 195(4276):1977;413-414.
20. Ferm V.H., Willhite C., Kilham L. Teratogenic effects of ribavirin on hamster and rat embryos. Teratology. 17(1):1978;93-101.
21. Kochhar D.M., Penner J.D., Knudsen T.B. Embryotoxic teratogenic and metabolic effects of ribavirin in mice. Toxicol. Appl. Pharmacol. 52(1):1980;99-112.
22. Rao K.P.S., Rahiman M.A. Cytogenetic effects of ribavirin on mouse bone marrow. Mutat. Res. 224:1989;213-218.
23. Phillips M.D., Nascimbeni B., Tice R.R., Shelby M.D. Induction of micronuclei in mouse bone marrow cells: an evaluation of nucleoside analogues used in the treatment of AIDS. Environ. Mol. Mutagen. 18(3):1991;168-183.
24. Narayana K., D'Souza U.J.A., Rao K.P.S. Ribavirin-induced sperm shape abnormalities in Wistar rat. Mutat. Res. 513:2002;193-196.
25. Narayana K., D'Souza U.J.A., Rao K.P.S. Possible reasons for spontaneous incidence of micronucleus in rodents. Indian J. Physiol. Pharmacol. 43(4):1999;515-517.
26. Schmid W. The micronucleus test. Mutat. Res. 31:1975;9-15.
27. Mathew G., Rahiman M.A., Vijayalaxmi K.K. In vivo genotoxic effects in mice of metacid 50, an organophosphorus insecticide. Mutagenesis. 5(2):1990;147-149.
28. W.U. Muller, C. Streffer, Micronucleus assay, in: G. Obe (Ed.), Advances in Mutagenesis Research-5, Springer, New York, 1994, pp. 1-134.
29. Heddle J.A., Cimino M.C., Hayashi M., Romagna F., Shelby M.D., Tucker J.D., Vanaparys Ph., MacGregor J.T. Micronuclei as an index of cytogenetic damage: past, present and future. Environ. Mol. Mutagen. 18:1991;277-291.
30. Hayashi M., Safuni T., Ishidate M. Jr. An application of acridine orange fluorescent staining to the micronucleus test. Mutat. Res. 120:1983;241-247.
31. Midander J., Revesz L. The frequency of micronuclei as a measure of cell survival in irradiated cell populations. Int. J. Radiat. Biol. 38:1980;237-242.
32. Lee H.J., Pawlak K., Nguyen B.T., Robins R.K., Sadee W. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin and selenazofurin studied in mouse lymphoma cell culture. Cancer Res. 45(11 Pt. 1):1985;5512-5520.
33. Collaborative Study Group, Sex-difference in the micronucleus test, Mutat. Res. 172 (1986) 151-163.
34. Krishna G., Kropko M.L., Ciaravino V., Theiss J.C. Simultaneous micronucleus and chromosome aberration assessment in the rat. Mutat. Res. 264:1991;29-35.
35. G. Siou, L. Ganan, El-Haitem, Evaluation of clastogenic action of benzene by oral administration with 2 cytogenetic techniques in mouse and Chinese hamster, Mutat. Res. 90 (1981) 273-278.
36. Davis, R. Barale, G. Brun, R. Foster, T. Gunther, H. Hautefeuille, C.A. Vander-Heijden, A.G.A.C. Knap, R. Krowke, T. Kuroki, N. Laprieno, C. Malaveille, H.J. Merker, M. Manaco, P. Mossesso, H. Bartsch, Evaluation of the genetic and embryotoxic effects of bis(tri-n-butyltin) oxide (TBTO), a broad spectrum pesticide, in multiple in vivo and in vitro short term tests, Mutat. Res. 188 (1987) 65-95.
37. Joksic G., Stankovic M., Vasic V., Cakar M., Jokanovic M. Influence of ribavirin on the micronucleus formation and in vitro proliferation of human lymphocytes. Neoplasma. 47(5):2000;283-287.